
Genetic analysis company 23andMe (ME) announced this week it's declaring bankruptcy and pursuing a sale, leading many customers to pursue deleting their data from the company.
23andMe was founded in 2006 and became something of a frenzy as customers willingly spit into tubes to find out origins of their ancestry. 23andMe wanted to be more than merely a family history lesson, though: The company also sought health insights for customers, using genetic analysis to test for certain predipositions, inherited traits and possible genetic disorders and indicators. It went public via a SPAC in 2021.